1. Home
  2. Bills
  3. H.R. 601

H.R. 601 · 116th Congress · 2019–2020

Medical Cannabis Research Act of 2019

H.R. 601 in the 116th Congress (2019–2020) was introduced on Jan 16, 2019, sponsored by Matt Gaetz with 12 co-sponsors.

During the 116th Congress (2019–2020), Donald Trump was president, and Democrats held the House majority and Republicans the Senate majority.

Status
Introduced
Introduced
Jan 16, 2019
Co-sponsors
12
Policy area
Health

What it does

Medical Cannabis Research Act of 2019 This bill establishes a new, separate registration process for manufacturers of cannabis for research. As a part of this process, the Drug Enforcement Administration must annually assess whether there is an adequate and uninterrupted supply of research cannabis and register additional manufacturers.

Summary by the nonpartisan Congressional Research Service.

Sponsor

Matt Gaetz (R-FL). Co-sponsors: 8 Democrats, 4 Republicans.

Where it stands

  • IntroducedJan 16, 2019
  • Passed the House—
  • Passed the Senate—
  • Sent to the President—
  • Became law—

Latest action: Referred to the Subcommittee on Crime, Terrorism, and Homeland Security. (Mar 4, 2019)

Other Health bills in the 116th Congress

Committees

More

From GovInfo bill records, Congressional Research Service summaries, Voteview roll calls and lobbying reports.

Cite or embed this page

Capitol Receipts, “H.R. 601 (116th Congress): Medical Cannabis Research Act of 2019,” https://www.capitolreceipts.com/bill/116-hr-601/medical-cannabis-research-act-of-2019 (accessed 2026-10-17).